Your browser doesn't support javascript.
loading
Novel TSPO-targeted Doxorubicin Prodrug for Colorectal Carcinoma Cells.
Jia, Jemianne B; Ling, Xiaoxi; Xing, Minzhi; Ludwig, Johannes M; Bai, Mingfeng; Kim, Hyun S.
Affiliation
  • Jia JB; Interventional Oncology Translational Laboratory, University of Pittsburgh School of Medicine, Pittsburgh, PA, U.S.A.
  • Ling X; Department of Radiology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, U.S.A.
  • Xing M; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, U.S.A.
  • Ludwig JM; Interventional Oncology Translational Laboratory, University of Pittsburgh School of Medicine, Pittsburgh, PA, U.S.A.
  • Bai M; Section of Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, U.S.A.
  • Kim HS; Interventional Oncology Translational Laboratory, University of Pittsburgh School of Medicine, Pittsburgh, PA, U.S.A.
Anticancer Res ; 40(10): 5371-5378, 2020 Oct.
Article in En | MEDLINE | ID: mdl-32988856
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prodrugs / Colorectal Neoplasms / Doxorubicin / Receptors, GABA Limits: Humans Language: En Journal: Anticancer Res Year: 2020 Document type: Article Affiliation country: United States Country of publication: Greece
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prodrugs / Colorectal Neoplasms / Doxorubicin / Receptors, GABA Limits: Humans Language: En Journal: Anticancer Res Year: 2020 Document type: Article Affiliation country: United States Country of publication: Greece